We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
24 Jan 2022 - 27 Jan 2022

Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany

By LabMedica International staff writers
Posted on 24 Nov 2021
Print article
Illustration
Illustration

The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19.

The biannual EuroMedLab congress is jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC; Lombardia, Italy), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM; Milano, Italy), and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL; Berlin, Germany). The event has proven to be one of the leading forums to bring together scientists, laboratory specialists, clinicians, and industry colleagues in the field of clinical chemistry and laboratory medicine.

The 24th EuroMedLab would have been the first major IFCC/EFLM conference to be held following a long delay caused by the pandemic and was expected to provide an excellent opportunity to bring together laboratory specialists from many national societies both physically and virtually. At EuroMedLab Congress 2021, attendees were expected to experience the outstanding scientific program, featuring innovative and diverse educational opportunities that incorporate the best of clinical laboratory medicine and in vitro diagnostics, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and much more. In addition to the scientific program, excellent social opportunities had been organized for the attendees to enjoy many attractions in Munich.

However, at a time when the EuroMedLab Congress 2021 was in the final stages of preparation, Germany has been hit very hard by a fourth COVID-19 wave, particularly in the area of the venue in Munich. Travel warnings for Germany have been issued by some countries even for vaccinated individuals, making it potentially problematic to return home after the congress. The local government has announced lockdowns for the coming days in all areas, where the seven-day incidences exceed 1,000 in 100,000. Munich as the EuroMedLab venue is approaching this threshold. Keeping in mind the safety of all attendees, exhibitors and staff, the organizers have decided that an orderly meeting cannot be warranted under these conditions. Therefore, IFCC and EFLM, together with the Congress Organizing Committee have decided to postpone EuroMedLab Congress 2021. The organizers are currently looking into rescheduling in 2022 and will communicate a new date for the conference in the near future.

Related Links:
IFCC 
EFLM 
DGKL

Gold Supplier
Desktop Urine Analyzer
MONOZYME TX2000
New
Immunodiagnostic Analyzer
LiCA 5000
New
Gold Supplier
SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test
DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp)
New
POC RT-PCR COVID-19 Testing Platform
Convergys POC RT-PCR COVID-19 Testing Platform

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Illustration

Point-of-Care Lateral Flow Test Detects Bladder Cancer Using Urine Sample within Minutes

A breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care settings. SCIENION (Berlin,... Read more

Hematology

view channel
Image: Bone marrow aspirate from a patient with Acute Myeloid Leukemia: Blasts are the predominant population and have a high nuclear to cytoplasmic ratio and generally lack granules. (Photo courtesy of Professor Peter G. Maslak, MD)

Cord Blood and Matched Related Donor Transplantation Compared in Acute Myeloid Leukemia

The prognosis of primary refractory and relapsed acute myeloid leukemia is poor, with a five-year overall survival of less than 10%. Allogeneic hematopoietic stem cell transplantation (HSCT) is the only... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.